Literature DB >> 7513302

Meningococcal group A lipooligosaccharides (LOS): preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes.

J J Kim1, N J Phillips, B W Gibson, J M Griffiss, R Yamasaki.   

Abstract

Structural studies indicate that the neisserial lipooligosaccharides (LOS) are composed of an oligosaccharide (OS) portion with a phosphorylated diheptose (Hep) core attached to the toxic lipid A moiety. A conserved meningococcal LOS epitope, defined by monoclonal antibody (MAb) D6A, is expressed on group A and many group B and C meningococci of different LOS serotypes (J. J. Kim, R. E. Mandrell, H. Zhen, M. A. Apicella, J. T. Poolman, and J. M. Griffiss, Infect. Immun. 56:2631-2638, 1988). This MAb-defined D6A epitope is immunogenic in humans (M. M. Estabrook, R. E. Mandrell, M. A. Apicella, and J. M. Griffiss, Infect. Immun. 58:2204-2213, 1990; M. M. Estabrook, C. J. Baker, and J. M. Griffiss, J. Infect. Dis. 197:966-970, 1993). In this study, we characterize this important MAb-defined LOS epitope. Serotype L10 and L11 group A meningococal LOS were chemically modified and used to investigate what portion of the LOS molecule is important for expression of the conserved (D6A) epitope and serotype-associated LOS epitopes by use of immunoblotting techniques and selected MAbs as probes. Preliminary structural characterization of the LOS was also accomplished by electrospray ionization-mass spectrometry. Our results indicate the following. (i) Antibodies that recognize the serotype-associated or conserved LOS epitopes recognize the OS portion of the LOS. (ii) The phosphorylated diheptose core region of the OS is essential for expression of the conserved D6A epitope. (iii) The lipid portion of the molecule is important for optimum expression of the LOS epitopes. (iv) The proposed compositions of the O-deacylated LOS are consistent with the presence of a phosphorylated diheptose core and are as follows: for O-deacylated L10 LOS, 3Hex (hexose), 1HexNAc (N-acetylhexosamine), 2KDO (2-keto-3-deoxy-D-manno-octulosonic acid), 2Hep (heptose), 1PEA or 2PEA (phosphoethanolamine), and O-deacylated lipid A; and for O-deacylated L11 LOS, 2Hex, 1HexNAc, 2KDO, 2Hep, 2PEA, and O-deacylated lipid A. Because the phosphorylated diheptose core region of the LOS is essential for the formation of a conserved LOS epitope (D6A) that is immunogenic in humans, care should be taken to maintain stereochemical requirements for the expression of this conserved epitope in the design of effective, nontoxic LOS vaccines.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513302      PMCID: PMC186357          DOI: 10.1128/iai.62.5.1566-1575.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

1.  Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa.

Authors:  B A Crowe; R A Wall; B Kusecek; B Neumann; T Olyhoek; H Abdillahi; M Hassan-King; B M Greenwood; J T Poolman; M Achtman
Journal:  J Infect Dis       Date:  1989-04       Impact factor: 5.226

2.  Structure of the L5 lipopolysaccharide core oligosaccharides of Neisseria meningitidis.

Authors:  F Michon; M Beurret; A Gamian; J R Brisson; H J Jennings
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

3.  Type-specific antigens of group A Neisseria meningitidis: lipopolysaccharide and heat-modifiable outer membrane proteins.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

4.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.

Authors:  C M Tsai; C E Frasch
Journal:  Anal Biochem       Date:  1982-01-01       Impact factor: 3.365

5.  Measurement of the human immune response to meningococcal lipooligosaccharide antigens by using serum to inhibit monoclonal antibody binding to purified lipooligosaccharide.

Authors:  M M Estabrook; R E Mandrell; M A Apicella; J M Griffiss
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

6.  Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.

Authors:  W D Zollinger; R E Mandrell; J M Griffiss; P Altieri; S Berman
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

7.  Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry.

Authors:  B W Gibson; W Melaugh; N J Phillips; M A Apicella; A A Campagnari; J M Griffiss
Journal:  J Bacteriol       Date:  1993-05       Impact factor: 3.490

Review 8.  Meningococcal disease: still with us.

Authors:  H Peltola
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  Immunological basis of serum resistance of Neisseria gonorrhoeae.

Authors:  H Schneider; J M Griffiss; G D Williams; G B Pier
Journal:  J Gen Microbiol       Date:  1982-01

10.  Outer-membrane protein and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay.

Authors:  W D Zollinger; R E Mandrell
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

View more
  13 in total

1.  Alpha-1-acid (AAG, orosomucoid) glycoprotein: interaction with bacterial lipopolysaccharide and protection from sepsis.

Authors:  D F Moore; M R Rosenfeld; P M Gribbon; C P Winlove; C M Tsai
Journal:  Inflammation       Date:  1997-02       Impact factor: 4.092

2.  Influence of the length of the lipooligosaccharide alpha chain on its sialylation in Neisseria meningitidis.

Authors:  Chao-Ming Tsai; George Kao; Peixuan Zhu
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

3.  Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.

Authors:  Deborah H Schmiel; Elizabeth E Moran; Paul B Keiser; Brenda L Brandt; Wendell D Zollinger
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

4.  Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.

Authors:  Noëlle Mistretta; Delphine Seguin; Jerôme Thiébaud; Sandrine Vialle; Frédéric Blanc; Marina Brossaud; Philippe Talaga; Gunnstein Norheim; Monique Moreau; Bachra Rokbi
Journal:  J Biol Chem       Date:  2010-04-26       Impact factor: 5.157

5.  Lipooligosaccharide Structures of Invasive and Carrier Isolates of Neisseria meningitidis Are Correlated with Pathogenicity and Carriage.

Authors:  Constance M John; Nancy J Phillips; Richard Din; Mingfeng Liu; Einar Rosenqvist; E Arne Høiby; Daniel C Stein; Gary A Jarvis
Journal:  J Biol Chem       Date:  2015-12-11       Impact factor: 5.157

6.  Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Authors:  Gunnstein Norheim; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; Yared Merid; E Arne Høiby; Dominique A Caugant; Elisabeth Fritzsønn; Torill Tangen; Berhanu Melak; Degu Berhanu; Morten Harboe; Jan Kolberg; Einar Rosenqvist
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

7.  Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

Authors:  Gunnstein Norheim; Einar Rosenqvist; Abraham Aseffa; Mohammed Ahmed Yassin; Getahun Mengistu; Afework Kassu; Dereje Fikremariam; Wegene Tamire; E Arne Høiby; Tsegaye Alebel; Degu Berhanu; Yarid Merid; Morten Harboe; Dominique A Caugant
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

8.  Activation of toll-like receptor 2 (TLR2) and TLR4/MD2 by Neisseria is independent of capsule and lipooligosaccharide (LOS) sialylation but varies widely among LOS from different strains.

Authors:  Alison C Pridmore; Gary A Jarvis; Constance M John; Dominic L Jack; Steven K Dower; Robert C Read
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

9.  Profiles of structural heterogeneity in native lipooligosaccharides of Neisseria and cytokine induction.

Authors:  Constance M John; Mingfeng Liu; Gary A Jarvis
Journal:  J Lipid Res       Date:  2008-10-02       Impact factor: 5.922

10.  Monoclonal antibodies against Haemophilus lipopolysaccharides: clone DP8 specific for Haemophilus ducreyi and clone DH24 binding to lacto-N-neotetraose.

Authors:  S Borrelli; E L Roggen; D Hendriksen; J Jonasson; H J Ahmed; P Piot; P E Jansson; A A Lindberg
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.